Successful Treatment of New-Onset Pediatric Nephrotic Syndrome With Rituximab as a First-Line Therapy
Kidney Int Rep
.
2022 Oct 22;7(12):2750-2751.
doi: 10.1016/j.ekir.2022.10.016.
eCollection 2022 Dec.
Authors
Xiaojing Zhang
1
,
Yanyan Jin
1
,
Qiuyu Li
1
,
Yi Xie
1
,
Fei Liu
1
,
Guoping Huang
1
,
Junyi Chen
1
,
Haidong Fu
1
,
Jingjing Wang
1
,
Huijun Shen
1
,
Jianhua Mao
1
Affiliation
1
Department of Nephrology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
PMID:
36506238
PMCID:
PMC9727513
DOI:
10.1016/j.ekir.2022.10.016
No abstract available